KPMA to oppose against KORUS FTA deals on drugs.

Published: 2007-02-28 06:58:00

Updated: 2007-02-28 06:58:00

The Korea Pharmaceutical Manufacturers Association (KPMA) indicated that the government should not use the pharmaceutical issue in the 8th KORUS FTA negotiation meeting as scheduled to hold in Seoul in coming March as a scape goat but take a normal deal in a reciprocal principle.

In the genera...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK